Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Are fixed-dose combination antihypertensives suitable as first-line therapy?
Sverre E. Kjeldsen, Franz H. Messerli, Chern‐En Chiang, et al.
Current Medical Research and Opinion (2012) Vol. 28, Iss. 10, pp. 1685-1697
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension
Gianfranco Parati, Sverre E. Kjeldsen, António Coca, et al.
Hypertension (2021) Vol. 77, Iss. 2, pp. 692-705
Open Access | Times Cited: 187
Updated National and International Hypertension Guidelines: A Review of Current Recommendations
Sverre E. Kjeldsen, Ross D. Feldman, Lisheng Liu, et al.
Drugs (2014) Vol. 74, Iss. 17, pp. 2033-2051
Open Access | Times Cited: 119
Blood pressure control in hypertension. Pros and cons of available treatment strategies
Giuseppe Mancia, Federico Rea, Cesare Cuspidi, et al.
Journal of Hypertension (2016) Vol. 35, Iss. 2, pp. 225-233
Closed Access | Times Cited: 52
Triple Combination Therapy in Hypertension: The Antihypertensive Efficacy of Treatment with Perindopril, Amlodipine, and Indapamide SR
Dénes Páll, Ildikó Szántó, Zoltán Szabó
Clinical Drug Investigation (2014) Vol. 34, Iss. 10, pp. 701-708
Open Access | Times Cited: 48
Single-Pill Combination to Improve Hypertension Treatment: Pharmaceutical Industry Development
Magdalena Paczkowska-Walendowska, Szymon Sip, Rafał Staszewski, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 7, pp. 4156-4156
Open Access | Times Cited: 13
Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
Sverre E. Kjeldsen, Tonje A. Aksnes, Luís M. Ruilope
Drugs in R&D (2014) Vol. 14, Iss. 2, pp. 31-43
Open Access | Times Cited: 24
Single-Pill, Triple Antihypertensive Therapy in Rural Sub-Saharan Africa: Preliminary Experience
Clara Stroppa, Isabella Hunjan, Alice Umulisa, et al.
Cardiology and Therapy (2024) Vol. 13, Iss. 2, pp. 431-442
Open Access | Times Cited: 2
NAD(P)H:Quinone Oxidoreductase 1 Activation Reduces Blood Pressure Through Regulation of Endothelial Nitric Oxide Synthase Acetylation in Spontaneously Hypertensive Rats
Yong Hoon Kim, Jin-Hee Hwang, Kyung‐Soo Kim, et al.
American Journal of Hypertension (2014) Vol. 28, Iss. 1, pp. 50-57
Open Access | Times Cited: 20
First look at new 2018 joint ESH/ESC Guidelines on diagnosis and management of hypertension
М. V. Ionov, Н. Э. Звартау, А. О. Конради
Arterial’naya Gipertenziya (Arterial Hypertension) (2018) Vol. 24, Iss. 3, pp. 351-358
Open Access | Times Cited: 20
Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile
Sverre E. Kjeldsen, Domenic Sica, Hermann Haller, et al.
Journal of Hypertension (2014) Vol. 32, Iss. 12, pp. 2488-2498
Open Access | Times Cited: 15
A randomized, double-blind study to evaluate the efficacy and safety of a single-pill combination of telmisartan 80 mg/amlodipine 5 mg versus amlodipine 5 mg in hypertensive Asian patients
Dingliang Zhu, Pingjin Gao, Werner Holtbruegge, et al.
Journal of International Medical Research (2014) Vol. 42, Iss. 1, pp. 52-66
Open Access | Times Cited: 8
Costs of current antihypertensive therapy in Switzerland: an economic evaluation of 3,489 patients in primary care
HH Schäfer, U Scheunert
Schweizerische medizinische Wochenschrift (2013)
Open Access | Times Cited: 8
A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide
J. W. Bryant, Luís M. Ruilope, J. Segura
Vascular Health and Risk Management (2013), pp. 521-521
Open Access | Times Cited: 7
Antihypertensive combination therapy in primary care offices: results of a cross-sectional survey in Switzerland
Walter E Kaiser, Susanne Roas, Felix Bernhart, et al.
International Journal of General Medicine (2014), pp. 549-549
Open Access | Times Cited: 4
An overview of fixed-dose combinations of antihypertensive drugs in South Africa
Natalie Schellack, Lucille Malan
South African Family Practice (2014) Vol. 56, Iss. 4, pp. 206-211
Open Access | Times Cited: 4
Efficacy and Tolerability of Telmisartan Plus Amlodipine in Asian Patients Not Adequately Controlled on Either Monotherapy or on Low-Dose Combination Therapy
Dingliang Zhu, Pingjin Gao, Nobutaka Yagi, et al.
International Journal of Hypertension (2014) Vol. 2014, pp. 1-11
Open Access | Times Cited: 3
Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses
Sverre E. Kjeldsen, Gloria Cha, Giuseppe Villa, et al.
The Journal of Clinical Pharmacology (2016) Vol. 56, Iss. 9, pp. 1120-1129
Open Access | Times Cited: 2
Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients
Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis
Current Medical Research and Opinion (2013) Vol. 29, Iss. 7, pp. 791-792
Open Access | Times Cited: 2
Eficacia y seguridad en la vida real de amlodipino/irbesartán en combinación fija en el tratamiento de la hipertensión en América Latina: estudio PARCERIA
Álvaro J. Ruiz, Diego Funes, Cláudio Higa, et al.
Revista Colombiana de Cardiología (2024) Vol. 30, Iss. 6
Open Access
Real-life effectiveness and safety of fixed amlodipine/irbesartan in hypertension management in Latin America: the PARCERIA study
Álvaro J. Ruiz, Diego Funes, Cláudio Higa, et al.
Revista Colombiana de Cardiología (2024) Vol. 30, Iss. 6
Open Access
Telmisartan in combination with hydrochlorothiazide 12.5 mg for the management of patients with hypertension
Steen Neldam, Helmut Schumacher, Sverre E. Kjeldsen, et al.
Current Medical Research and Opinion (2014) Vol. 30, Iss. 9, pp. 1715-1724
Open Access | Times Cited: 1
Treatment of Resistant Hypertension
Gino Seravalle, Guıdo Grassı, Giuseppe Mancia
Updates in hypertension and cardiovascular protection (2018), pp. 639-652
Closed Access | Times Cited: 1
Polypharmacology in Clinical Applications: Cardiovascular Polypharmacology
Zhiguo Wang, Baofeng Yang
Springer eBooks (2022), pp. 133-198
Closed Access | Times Cited: 1
Real-World Effectiveness and Safety of Single-pill Combination of Amlodipine/Valsartan or Amlodipine/Valsartan/Hydrochlorothiazide in Patients with Hypertension from the Philippines
Jorge Sison, Shari G. Francisco
(2014)
Closed Access
Optimization of Antihypertensive Drug Treatment in Resistant Hypertension
Giuseppe Mancia
Updates in hypertension and cardiovascular protection (2016), pp. 139-149
Closed Access
Page 1 - Next Page

Scroll to top